BioNTech to shutter sites in Germany, Singapore as no buyers emerge

German COVID—19 vaccine maker BioNTech NASDAQ:BNTX said on Monday it would close sites in Germany and Singapore because it failed to find buyers after pivoting away from pandemic-era manufacturing."Despite the best efforts of all those involved and a wide-ranging sales process, it has unfortunately…